Clinical trial
A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
NCT01608061 is registered in ClinicalTrials.gov with Functional Neuromodulation Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Twelve Month Double-blind Randomized Controlled Feasibility Study to Evaluate the Safety, Efficacy and Tolerability of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
- Lead sponsor
- Functional Neuromodulation Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- September 30, 2018
- Enrollment
- 42 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.